DOW JONES23,123.60+443.61 1.96%
S&P 5002,711.15+47.47 1.78%
NASDAQ7,973.21+59.97 0.76%

H.C. Wainwright Maintains Buy on Syndax Pharmaceuticals, Raises Price Target to $17

H.C. Wainwright maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $15 to $17.

Benzinga · 01/13/2020 12:33

H.C. Wainwright maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Buy and raises the price target from $15 to $17.